ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 6.48
+0.17 (2.69%)
Feb 12, 2026, 4:29 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 31.72 million as of February 12, 2026. Its market cap has increased by 41.06% in one year.
Market Cap
31.72M
Enterprise Value
31.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.48
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 31.72M, a decrease of -12.16%. That is a compound annual growth rate of -0.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 31.72M | 1.77% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 77.58M |
| Hemogenyx Pharmaceuticals | 57.51M |
| SkinBioTherapeutics | 51.13M |
| hVIVO | 48.31M |
| Ondine Biomedical | 41.09M |
| Poolbeg Pharma | 32.43M |
| Arecor Therapeutics | 28.70M |
| Aptamer Group | 25.62M |